Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales.

Journal: The Journal of infection
PMID: 29289561

Abstract

INTRODUCTION: The implementation of the Hib conjugate vaccine in the United Kingdom in 1992 resulted in a rapid decline in invasive Hib disease across all age groups. However, a resurgence in 2000-2002 prompted the introduction of additional control measures, including a routine 12-month booster in 2006. Here we describe results from a national serosurvey in children eligible for the 12-month booster and recent Haemophilus influenzae epidemiology in England and Wales.

Authors

  • Sarah Collins
    Immunisation Department, Public Health England, London, UK.
  • David Litt
    Respiratory and Vaccine Preventable Bacterial Reference Unit, Public Health England, London, UK.
  • Rachael Almond
    Meningococcal Reference Unit, Public Health England, Manchester, UK.
  • Jamie Findlow
    Meningococcal Reference Unit, Public Health England, Manchester, UK.
  • Ezra Linley
    Meningococcal Reference Unit, Public Health England, Manchester, UK.
  • Mary Ramsay
    Immunisation Department, Public Health England, London, UK.
  • Ray Borrow
    Meningococcal Reference Unit, Public Health England, Manchester, UK.
  • Shamez Ladhani
    Immunisation Department, Public Health England, London, UK; Paediatric Infectious Diseases Research Group, St. George's University of London, London, UK. Electronic address: shamez.ladhani@phe.gov.uk.

Keywords

External Resources

Popular Topics
Recent Journals